Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population

Author(s): Chakradhara Rao S. Uppugunduri, Marc Ansari

Journal Name: Drug Metabolism Letters

Volume 10 , Issue 2 , 2016

Become EABM
Become Reviewer
Call for Editor


Major lacunae exist in our understanding of how developmental changes in drug biotransformation influence drug’s exposure and thus its efficacy and toxicity in children. It is not just about smaller weight in children, which modifies the pattern of the drug's exposure. There are developmental, functional changes in organ systems, liver to body mass ratios, and changes in metabolism. Understanding these changes and conducting studies to obtain data on ontogeny of drug metabolizing enzymes is essential for implementation of personalized dosing schedules in the pediatric population.

Keywords: Children, drug metabolism, enzyme, ontogeny.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 13 June, 2016
Page: [72 - 74]
Pages: 3
DOI: 10.2174/1872312810666160224143443

Article Metrics

PDF: 55